Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 Laser vs Microbotox for Wide Facial Pores
NCT05923996Phase 1Not yet recruiting
- Sponsor
- Assiut University
- Start
- Feb 2024
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 1, randomised, open-label trial of botulinum toxin type A (2 arms), sponsored by Assiut University. Primary endpoints: Pore Score at 3 months, Sebum Score at 3 months and 1 more. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
botulinum toxin type A
Beyond the preview
Go deeper on NCT05923996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05923996.